A Decision Support Tool for Allogeneic Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease: Acceptability and Usability Study

BACKGROUND: Individuals living with sickle cell disease (SCD) may benefit from a variety of disease-modifying therapies, including hydroxyurea, voxelotor, crizanlizumab, L-glutamine, and chronic blood transfusions. However, allogeneic hematopoietic stem cell transplantation (HCT) remains the only no...

Descripción completa

Detalles Bibliográficos
Autores principales: Veludhandi, Anirudh, Ross, Diana, Sinha, Cynthia B, McCracken, Courtney, Bakshi, Nitya, Krishnamurti, Lakshmanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587189/
https://www.ncbi.nlm.nih.gov/pubmed/34709190
http://dx.doi.org/10.2196/30093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587189/
https://www.ncbi.nlm.nih.gov/pubmed/34709190
http://dx.doi.org/10.2196/30093

Ejemplares similares